Every SEC Form 3/4/5 on record for this filer (CIK 1398940) — 3 issuers, 48 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Chief Medical Officer | 2022-11-17 → 2026-03-27 | 16 | −$9M |
| FMTX | Forma Therapeutics Holdings, Inc. | Director · lapsed | 2022-01-13 → 2022-10-14 | 4 | — |
| STRO | SUTRO BIOPHARMA, INC. | Chief Medical Officer · lapsed | 2018-09-26 → 2022-03-07 | 12 | $49,995 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-03-26 | Sell | 15,000 | $104.79 | $2M | 84,115 |
| PTGX | 2026-01-27 | Sell | 5,000 | $82.00 | $410,000 | 84,115 |
| PTGX | 2026-01-26 | Sell | 5,000 | $82.28 | $411,400 | 84,115 |
| PTGX | 2026-01-23 | Sell | 13,151 | $82.42 | $1M | 84,115 |
| PTGX | 2026-01-20 | Sell | 9,514 | $82.48 | $784,715 | 97,266 |
| PTGX | 2025-11-17 | Sell | 2,712 | $84.77 | $229,896 | 81,180 |
2 of 3 issuers are covered and open a security page; the rest are on file here only.
